Phase 1 · Cincinnati area, OH
Phase 1 clinical trials in Cincinnati area, OH
32 recruiting studies have a site in the Cincinnati area. This page includes nearby cities such as Mason, West Chester, Fairfield, Blue Ash.
32 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Beachwood, OH + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Pfizer
- Location
- Cincinnati, OH + 9 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
Scholar Rock, Inc.
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
Inventprise Inc.
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1/Phase 2
Assessing Pulmonary Changes in HSCT
Children's Hospital Medical Center, Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 3+
- RecruitingHealthy volunteersPhase 1/Phase 2
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
Children's Hospital Medical Center, Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nationwide Children's Hospital
- Location
- Cincinnati, OH + 1 other US site
- Eligibility basics
- Ages 1–21
- RecruitingHealthy volunteersPhase 1
Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion
Jose Cancelas
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults
Children's Hospital Medical Center, Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 6+
- RecruitingHealthy volunteersEarly Phase 1
Effect of C-peptide on Hypoglycemic Counterregulation
University of Cincinnati
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–40
- RecruitingPhase 1
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Astellas Institute for Regenerative Medicine
- Location
- Cincinnati, OH + 3 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Novartis Pharmaceuticals
- Location
- Cincinnati, OH + 10 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Merck Sharp & Dohme LLC
- Location
- Cincinnati, OH + 20 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 1
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I…
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Location
- Cincinnati, OH + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Ascidian Therapeutics, Inc
- Location
- Cincinnati, OH + 8 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Disc Medicine, Inc
- Location
- Cincinnati, OH + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Jazz Pharmaceuticals
- Location
- Cincinnati, OH + 20 other US sites
- Eligibility basics
- Ages 12–75
- RecruitingPhase 1
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Pfizer
- Location
- Cincinnati, OH + 10 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 1/Phase 2
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
UniQure Biopharma B.V.
- Location
- Cincinnati, OH + 9 other US sites
- Eligibility basics
- Ages 18–65 · Men only
- RecruitingPhase 1/Phase 2
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Opus Genetics, Inc
- Location
- Cincinnati, OH + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study of GS-0415 and How It Works in People With HIV
Gilead Sciences
- Location
- Cincinnati, OH + 14 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1/Phase 2
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Tr1X, Inc.
- Location
- Cincinnati, OH + 7 other US sites
- Eligibility basics
- Ages 18–65
Who these studies look for
Phase 1 studies often have narrow eligibility: specific age and weight ranges, no recent participation in another study, no nicotine, and limits on medications. Some Phase 1 studies recruit patients rather than healthy volunteers, so check each listing.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.